Cita APA

Ehlén, Å., Brennan, D. J., Nodin, B., O'Connor, D. P., Eberhard, J., Alvarado-Kristensson, M., . . . Jirström, K. (2010). Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. BioMed Central.

Citación estilo Chicago

Ehlén, Åsa, et al. Expression of the RNA-binding Protein RBM3 Is Associated With a Favourable Prognosis and Cisplatin Sensitivity in Epithelial Ovarian Cancer. BioMed Central, 2010.

Cita MLA

Ehlén, Åsa, et al. Expression of the RNA-binding Protein RBM3 Is Associated With a Favourable Prognosis and Cisplatin Sensitivity in Epithelial Ovarian Cancer. BioMed Central, 2010.